| Financial Year |
March 31 2023 |
| Monetary Funds |
264,798,610.00 |
| Held-for-trading Financial Assets |
825,752,334.76 |
| Notes Receivable |
133,698,744.64 |
| Accounts Receivable |
466,173,970.18 |
| Advances to Suppliers |
101,261,163.02 |
| Other Receivables |
114,798,416.81 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
493,930,709.01 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
30,000,000.00 |
| Other Current Assets |
1,646,361.98 |
| Total Current Assets |
2,451,971,111.40 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
25,489,573.25 |
| Fixed Assetes |
738,143,095.49 |
| Under-construction Projects |
163,552,385.88 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
102,589,776.89 |
| R&D expenses |
-- |
| Goodwill |
106,104.49 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
48,694,244.91 |
| Other Non-Current Assets |
51,184,674.52 |
| Sub-Total of Non-Current Assets |
1,140,652,151.40 |
| Total Assets |
3,592,623,262.80 |
| Short-Term Loans |
69,939,679.44 |
| Trading Financial liabilities |
-- |
| Notes Payable |
93,883,649.46 |
| Accounts Payable |
164,454,779.78 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
40,333,850.28 |
| Taxes Payable |
31,163,422.12 |
| Interest Payable |
109,764.77 |
| Dividend Payable |
559,615.47 |
| Other payables |
29,054,190.48 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,697,401.10 |
| Other Current Liabilities |
34,890,339.87 |
| Sub-Total of Current Liabilities |
477,503,319.25 |
| Long-term Loans |
367,384,499.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
68,480,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
19,742,413.76 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
822,926,998.34 |
| Total Liabilities |
1,300,430,317.59 |
| Paid-In Capital(Or Share Stock) |
399,553,571.00 |
| Capital Surplus |
696,086,894.25 |
| Surplus Reserve |
217,856,943.91 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
993,821,068.90 |
| Minority Stockholder's Interest |
-9,380,908.61 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,301,573,853.82 |
| Owner's Equity（Stockholder's Equity） |
2,292,192,945.21 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,592,623,262.80 |
